Plain-English translation of NCT06082180 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
Papillary thyroid cancer is the most common type of thyroid cancer and usually has a good outlook. When doctors remove the thyroid, they must decide whether to also remove lymph nodes in the central neck area. This trial compares two surgical approaches: one where doctors remove these lymph nodes during surgery, and one where they don't. The goal is to understand which approach helps patients recover better and have fewer complications over time.
Doctors don't fully agree on whether removing lymph nodes during initial thyroid surgery helps prevent cancer from coming back. While removing lymph nodes can find hidden cancer cells, it may also increase the risk of nerve damage and low calcium levels. This trial will help determine whether this extra surgery truly benefits patients in the long run.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two surgical approaches: one group will have their thyroid and central neck lymph nodes removed, while the other group will have only their thyroid removed. After surgery, you will have regular follow-up visits where doctors check your recovery, measure thyroglobulin levels (a tumor marker in your blood), and monitor for any signs of recurrence. The study plans to follow participants over time to compare how well each approach works in preventing cancer from returning.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China